Nasal Polyposis and its Management: Pathogenesis, Medical and Surgical Treatment, 2nd Edition (Original Publisher)

Nasal Polyposis and Its Management: Pathogenesis, Medical and Surgical Treatment (2nd Edition, 2024) is a meticulously updated clinical guide tailored for otolaryngologists, rhinologists, allergists, pulmonologists, and medical residents involved in the diagnosis and treatment of chronic rhinosinusitis with nasal polyps (CRSwNP). This comprehensive reference unites foundational science with practical clinical application, making it a critical asset for both academic learning and day-to-day practice.

 Key Features & Highlights:

• Covers the full pathophysiological mechanisms behind nasal polyposis
• Detailed exploration of both pharmacologic and surgical management techniques
• Reviews the latest biologic therapies and immunomodulatory approaches
• Integrates clinical practice guidelines and real-world treatment outcomes
• High-resolution illustrations and endoscopic images support procedural learning
• Contributions from internationally recognized experts in ENT and respiratory medicine

 Topics Covered:
This second edition includes core chapters on:

• Inflammatory pathways and molecular pathogenesis of nasal polyps
• Diagnostic criteria and imaging in CRSwNP
• Corticosteroid therapy and antibiotic use
• Biologic treatments (e.g., anti-IL-5, anti-IgE therapies)
• Surgical techniques including functional endoscopic sinus surgery (FESS)
• Long-term follow-up and recurrence prevention strategies

 About the Author:
The editorial team includes renowned ENT surgeons and researchers who have published extensively on sinonasal diseases and contributed to international treatment guidelines. Their combined expertise ensures the book is both scientifically robust and clinically applicable.

 File Details:

• Format: PDF
• File Size: Approx. 18 MB
• Language: English
• Compatibility: Compatible with Kindle, iOS, Android, PC, and Mac devices

 Frequently Asked Questions

Q1: Does this edition include the latest treatment innovations such as biologics?
A: Yes, the 2nd edition thoroughly discusses emerging biologic therapies for nasal polyps, including the latest evidence on monoclonal antibodies and their clinical application.

Q2: Is the book suitable for ENT residents preparing for board exams?
A: Absolutely. The structured approach, evidence-based content, and integration of clinical guidelines make it an excellent study resource for residents and fellows.